BSE filing, NSE: GODREJCP. Summary written from the filing by ALFA Finder's alert engine.
Godrej Consumer Products Ltd: key numbers
- Share price
- ₹822.00
- Market cap
- ₹84,129 Cr
- Revenue (annual)
- ₹15,178 Cr
- Net profit (annual)
- ₹1,861 Cr
- P/E (TTM)
- 44.0×Sector 38.3×
- Promoter holding
- 53.05%+0.00% QoQ
- FII holding
- 10.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Godrej Consumer Products Ltd
All →Godrej Consumer Products Production Started
Godrej Consumer Products' Indonesian subsidiary GCPI has commenced commercial production at its Kendal facility today, October 23, 2026. The plant manufactures household insecticides for the Indonesian market and exports.
Godrej Consumer Products Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Godrej Consumer Products Other Announcement
Godrej Consumer Products Limited submitted the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Godrej Consumer Products Debt & Borrowing: ₹3,000 Cr
Godrej Consumer Products Limited confirmed the utilization of proceeds for Commercial Papers issued during Q2 FY2026-27. Total issuances for the quarter amounted to ₹3,000 Crore.
- Value
- ₹3,000 Cr
Godrej Consumer Products Annual General Meeting
Godrej Consumer Products' shareholders approved the appointment of Aasif Malbari as Managing Director and CEO via postal ballot, as confirmed by the Scrutinizer's report.
Godrej Consumer Products Debt & Borrowing
Godrej Consumer Products Limited announced record dates for the redemption of three Commercial Papers maturing in November and December 2026.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.